Výsledky vyhledávání - Delea, Thomas E

Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma Autor Amdahl, Jordan, Chen, Lei, Delea, Thomas E.

Získat plný text Získat plný text Získat plný text

Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzum... Autor Delea, Thomas E., Kartashov, Alex, Sharma, Puza P.

Získat plný text Získat plný text Získat plný text

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer Autor Hagiwara, May, Delea, Thomas E., Cong, Ze, Chung, Karen

Získat plný text Získat plný text Získat plný text

Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2− Advanced Breast Cancer Autor Stellato, Daniel, Thabane, Marroon, Eichten, Caitlin, Delea, Thomas E.

Získat plný text Získat plný text Získat plný text

Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom Autor Amdahl, Jordan, Diaz, Jose, Sharma, Arati, Park, Jinhee, Chandiwana, David, Delea, Thomas E.

Získat plný text Získat plný text Získat plný text

Cost Effectiveness of Labetalol and Propranolol in the Treatment of Hypertension Among Blacks Autor Oster, Gerry, Huse, Daniel M., Delea, Thomas E., Savage, Daniel D., Colditz, Graham A.

Získat plný text Získat plný text

Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor-and HER2-Positive Metastatic Breast Cancer Autor Delea, Thomas E., Hawkes, Carol, Amonkar, Mayur M., Lykopoulos, Konstantinos, Johnston, Stephen R. D.

Získat plný text Získat plný text Získat plný text

Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia Autor Hatswell, Anthony J., Thompson, Gwilym J., Maroudas, Penny A., Sofrygin, Oleg, Delea, Thomas E.

Získat plný text Získat plný text Získat plný text

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease Autor Mallya, Usha G., Boklage, Susan H., Koren, Andrew, Delea, Thomas E., Mullins, C. Daniel

Získat plný text Získat plný text Získat plný text

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States Autor Delea, Thomas E., Zhang, Xinke, Amdahl, Jordan, Boyko, Diana, Dirnberger, Franziska, Campioni, Marco, Cong, Ze

Získat plný text Získat plný text Získat plný text

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom Autor Amdahl, Jordan, Manson, Stephanie C., Isbell, Robert, Chit, Ayman, Diaz, Jose, Lewis, Lily, Delea, Thomas E.

Získat plný text Získat plný text Získat plný text

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada Autor Delea, Thomas E., Weycker, Derek, Atwood, Mark, Neame, Dion, Alvarez, Fabián P., Forget, Evelyn, Langley, Joanne M., Chit, Ayman

Získat plný text Získat plný text Získat plný text

Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria Autor Delea, Thomas E., Sofrygin, Oleg, Palmer, James L., Lau, Helen, Munk, Veronica C., Sung, Jennifer, Charney, Alan, Parving, Hans-Henrik, Sullivan, Sean D.

Získat plný text Získat plný text Získat plný text

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer Autor Fasching, Peter A, Delea, Thomas E, Lu, Yen-Shen, De Boer, Richard, Hurvitz, Sara A, Moynahan, Aaron, Chandiwana, David, Lanoue, Brad, Hu, Huilin, Thuerigen, Astrid, O’Shaughnessy, Joyce

Získat plný text Získat plný text Získat plný text